Clinical Trials Logo

Orthopedic Surgery clinical trials

View clinical trials related to Orthopedic Surgery.

Filter by:

NCT ID: NCT00293631 Completed - Orthopedic Surgery Clinical Trials

Study of Lornoxicam or Ketorolac or Placebo for Post-Operative Pain After Bunionectomy

Start date: November 2005
Phase: Phase 2
Study type: Interventional

To determine whether a single dose of intravenous lornoxicam is superior to intravenous placebo for management of post-operative pain in patients who have surgical removal of a bunion on the lower extremity. One-fourth of patients in this study will receive a single dose of intravenous ketorolac for management of pain and one-fourth of patients in this study will receive a single dose of an intravenous placebo.

NCT ID: NCT00270075 Completed - Blood Transfusion Clinical Trials

A Study to Determine the Safety and Effectiveness of Epoetin Alfa in Facilitating Self-donation of Blood Before Surgery in Patients Who Are Not Anemic and Who Will be Undergoing Orthopedic or Heart and Blood Vessel Surgery

Start date: January 1990
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to determine whether epoetin alfa will enable self-donation of at least 4 units of blood during the 2-week period before surgery (which is a shorter period of time than the conventional 3-week blood donation period before surgery) in patients who are not anemic and who will be undergoing orthopedic or heart and blood vessel surgery. Epoetin alfa is a genetically engineered protein that stimulates red blood cell production.

NCT ID: NCT00270023 Completed - Blood Transfusion Clinical Trials

A Study to Determine the Effectiveness of Epoetin Alfa in Facilitating Self-donation of Blood Before Surgery in Non-anemic Patients Who Are Undergoing Orthopedic, Heart and Blood Vessel, or Breast Reduction Surgery; Performed in Combination With a Procedure to Reduce Blood Loss During Surgery.

Start date: n/a
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to determine the safety and effectiveness of epoetin alfa and whether epoetin alfa will enable self-donation of blood during an 11-day period before surgery (which is shorter than the conventional 3-week blood donation period before surgery) in patients who are not anemic and who will be undergoing orthopedic, heart and blood vessel, or breast reduction surgery. Epoetin alfa is a genetically engineered protein that stimulates red blood cell production. Normovolemic hemodilution (NVHD, withdrawal of a patient's blood immediately before surgery, immediate replacement of blood with an equal volume of fluid, and return of the withdrawn blood after completion of surgery; a procedure which reduces the loss of blood during surgery) will also be performed.

NCT ID: NCT00192894 Completed - Orthopedic Surgery Clinical Trials

New Methods to Detect a Decrease in Heart Function

Start date: May 2004
Phase: Phase 4
Study type: Observational

The purpose of this study was to evaluate the changes in heart function during onset of spinal anesthesia using a new and less invasive method, the LidcoTMplus.